Multilevel models improve precision and speed of IC50 estimates
Related Experiment Video
Updated: Mar 21, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
Daniel J Vis1,2, Lorenzo Bombardelli3, Howard Lightfoot4
1Center for Personalized Cancer Treatment (CPCT), Utrecht/Amsterdam, The Netherlands.
Aim:
Experimental variation in dose-response data of drugs tested on cell lines result in inaccuracies in the estimate of a key drug sensitivity characteristic: the IC50. We aim to improve the precision of the half-limiting dose (IC50) estimates by simultaneously employing all dose-responses across all cell lines and drugs, rather than using a single drug-cell line response.
Materials & Methods:
We propose a multilevel mixed effects model that takes advantage of all available dose-response data.
Results:
The new estimates are highly concordant with the currently used Bayesian model when the data are well behaved. Otherwise, the multilevel model is clearly superior.
Conclusion:
The multilevel model yields a significant reduction of extreme IC50 estimates, an increase in precision and it runs orders of magnitude faster.
Related Concept Videos
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Mechanistic Models: Compartment Models in Individual and Population Analysis
Pharmacodynamic Models: Linear Concentration–Effect Model
Pharmacodynamic Models: Emax Drug–Concentration Effect Model
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...

